Real-time enrollment status for this high-risk neuroblastoma clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 7:28 PM UTC
| NCT Number | NCT07549321 |
| Recruiting Status | Recruiting |
| Condition | High-Risk Neuroblastoma |
| Phase | PHASE2 |
| Target Enrollment | 144 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Renaissance Pharma Ltd. |
| Last Updated on CT.gov | August 14, 2026 (2 weeks ago) |
As of September 1, 2026: Clinical trial NCT07549321 is currently recruiting participants. This phase2 study for high-risk neuroblastoma is actively seeking new participants at 5 locations across the United States. The study is sponsored by Renaissance Pharma Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07549321 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07549321 was last updated 2 weeks ago (August 14, 2026). HelloStudys verifies this status automatically.